A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to assess the safety of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in participants with unresectable, locally advanced or metastatic hepatocellular carcinoma (HCC) with Child-pugh B7 or B8 cirrhosis.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rak wątroby w zaawansowanym stadium, którego nie można leczyć operacyjnie ani innymi miejscowymi terapiami.
- •Brak wcześniejszego leczenia ogólnego (w tym eksperymentalnymi lekami) na raka wątroby w zaawansowanym stadium.
- •Rak wątroby widoczny na badaniach obrazowych (przynajmniej jedna zmiana docelowa, która nie była leczona).
- •Stan ogólny pacjenta pozwala na udział w badaniu (zgodnie ze skalą ECOG 0-2).
- •Marskość wątroby typu Child-Pugh B7 lub B8.
- •Odpowiednia liczba komórek krwi i prawidłowe funkcjonowanie narządów.
- •Przewidywana długość życia co najmniej 12 tygodni.
- •Kobiety w wieku rozrodczym muszą zgadzać się na unikanie ciąży i oddawania komórek jajowych.
✗ Disqualifies
- •Ciąża lub karmienie piersią.
- •Wcześniejsze leczenie lekami wpływającymi na układ odpornościowy (np. agonisty CD137 lub terapie blokujące punkty kontrolne).
- •Przyjmowanie jakichkolwiek innych leków eksperymentalnych w ciągu ostatnich 28 dni.
- •Przeszłe leczenie wątroby metodami miejscowymi (np. wstrzyknięcia, embolizacja) w ciągu ostatnich 28 dni.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- June 30, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (62)
University of Arizona Cancer Center
Tucson, United States
UC San Diego Moores Cancer Center
La Jolla, United States
University of Southern California-Keck School of Medicine -1975 Zonal Ave
Los Angeles, United States
University of Southern California
Newport Beach, United States
University of California Irvine Medical Center
Orange, United States
California Liver Research Institute
Pasadena, United States
University of California Davis Medical Center
Sacramento, United States
Stanford Health Care
Stanford, United States
Harbor UCLA Medical Center
Torrance, United States
Cedars Sinai Comprehensive Transplant Center
West Hollywood, United States
Rocky Mountain Cancer Centers (Williams) - USOR
Denver, United States
Hartford Healthcare Cancer Institute at Hartford Hospital
Hartford, United States
George Washington University- Medical Faculty Associates
Washington D.C., United States
Washington DC VA Medical Center
Washington D.C., United States
Orlando Health Inc.
Orlando, United States
Northwestern University
Chicago, United States
University of Illinois Health Outpatient Care Center
Chicago, United States
The Duchossois Center for Advanced Medicine
Chicago, United States
University of Kentucky - Markey Cancer Center
Lexington, United States
LSU Health Baton Rouge
Baton Rouge, United States
Our Lady of the Lake Cancer Institute
Baton Rouge, United States
Tufts Medical Center
Boston, United States
Beth Israel Deaconess Medical Center
Boston, United States
Veterans Affairs Ann Arbor Healthcare System
Ann Arbor, United States
Barbara Ann Karmanos Cancer Institute
Detroit, United States
Henry Ford Health System
Detroit, United States
Saint Luke?s Hospital of Kansas City
Kansas City, United States
MorristownMedicalCenter
Morristown, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, United States
Rutgers Cancer Institute of New Jersey at University Hospital
Newark, United States
NYU Langone Hospital - Long Island
Mineola, United States
R.J. Zuckerberg Cancer Hospital/Northwell Health - BRANY - PPDS
New Hyde Park, United States
NYU Langone Medical Center
New York, United States
Icahn School of Medicine at Mount Sinai
New York, United States
Montefiore Medical Center
The Bronx, United States
James J Peters Veterans Administration Medical Center - NAVREF
The Bronx, United States
Levine Cancer Institute
Charlotte, United States
University Hospitals Cleveland Medical Center
Cleveland, United States
Dayton VA Medical Center - NAVREF - PPDS
Dayton, United States
The University of Oklahoma Health Sciences Center
Oklahoma City, United States
Kaiser Permanente Westside Medical Center
Hillsboro, United States
OHSU Knight Cancer Institute Hematology Oncology
Portland, United States
Jefferson Health Honickman Center
Philadelphia, United States
Veterans Affairs Pittsburgh Healthcare System - NAVREF - PPDS
Pittsburgh, United States
The West Clinic (East Campus)
Germantown, United States
Nashville General Hospital at Meharry
Nashville, United States
Liver Institute at Methodist Dallas
Dallas, United States
Moody Outpatient Center ? Parkland Health
Dallas, United States
Texas Oncology (Worth) - USOR
Dallas, United States
University of Texas Southwestern Medical Center
Dallas, United States
Texas Oncology - Denison Cancer Center
Denison, United States
Kelsey Research Foundation
Houston, United States
Michael E Debakey VA Medical Center - NAVREF - PPDS
Houston, United States
Houston Methodist Hospital
Houston, United States
Intermountain Healthcare
Murray, United States
Intermountain Cancer Center
St. George, United States
Inova Schar Cancer Institute
Falls Church, United States
Maryview Hospital, Inc.
Newport News, United States
Bon Secours St. Mary's Hospital
Richmond, United States
VCU Medical Center North Hospital
Richmond, United States
Virginia Mason Medical Center
Seattle, United States
Pan American Center for Oncology Trials, LLC
Rio Piedras, Puerto Rico
Trial contact
Reference Study ID Number: ML44719 https://forpatients.roche.com/
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.